Anmol Arora

Academic Clinical Fellow, University College London (UK)

Andrea Isoni

Founder and Chief AI Officer, AI Technologies (London, UK)

Annabel Painter

NHS doctor and honorary fellow in digital health, Imperial College London (UK)

Avantika Lal

Senior Data Scientist, Insitro (CA, USA)

Brandon Allgood

Chief Data Officer, FogPharma (WA, US)

Catherine Miller

CTO, Flatiron Health (NY, US)

Danny Ruta

Clinical Artificial Intelligence Lead, Guy's Cancer Centre (London, UK)

Eleonora Harwich

Academic Foundation Doctor, Cambridge University (UK)

Ellie Norris

Director, Data and Analytics Strategy for Clinical and Real-World Evidence IT, Merck (NY, US)

Harshita Sharma

Senior Researcher, Microsoft (Cambridge, UK)

Kamala Kalyani Maddali

President and Founder, Health Collaborations LLC (PA, US)

Mahendra Singh

Founder and CEO, Benovymed Healthcare (Mumbai, India)

Mary Jane Dykeman

Managing partner, INQ Law (Toronto, Canada)

Matt Archer

Director of Operations, The Surgical Consortium (Oxford, UK)

Mazin Gadir

Director of Strategic Partnerships, IQVIA (UAE)

Moez Draief

Managing Director, Mozilla.ai (London, UK)

Philippe Moingeon

Head of Application of AI to drug development, Servier Pharmaceuticals (Paris, France)

Preetaman Wadhwa

Strategic and operational commercial leader in the Pharmaceutical/Biotechnology industry (CA, US)

Radha Chitta

Senior Research Scientist, Zuva (Toronto, Canada)

Sandeep Reddy

Director MBA (Healthcare Management) Program, Deakin University (Victoria, Australia)

Shameer Khader

Executive Director of Precision Medicine and Computational Biology, Sanofi (MA, US)

Siddha Ganju

Manager, NVIDIA (CA, US)

AI-enabled cancer target prioritization with optimal profiles balancing novelty, confidence and commercial tractability